Lumicera Health Services Selected as a Partner In-Network Specialty Pharmacy for Anzupgo® (delgocitinib) cream

Lumicera Health Services Selected as a Partner In-Network Specialty Pharmacy for Anzupgo® (delgocitinib) cream

Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.

Lumicera and HealthBeacon: Partnering to Elevate Patient Care and Outcomes for Injectable Medications

Lumicera and HealthBeacon: Partnering to Elevate Patient Care and Outcomes for Injectable Medications

Lumicera and HealthBeacon are thrilled to announce a new strategic collaboration. This partnership brings together Lumicera’s expertise in specialty pharmacy services and HealthBeacon’s leadership in digital health to improve outcomes for patients on injectable therapies, one dose at a time.